Brennan Doyle Email
V.P. - Head Investor Relations . BioXcel Therapeutics
New Haven, CT
Locationb*****@bioxceltherapeutics.com
Primary EmailHow to contact Brennan Doyle
Join and see Brennan's contact info for free!Current Roles
Employees:
279Revenue:
$43.2MAbout
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. The company's two most advanced clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.BioXcel Therapeutics Address
555 Long Wharf DriveNew Haven, CT
United States